Later on, another study from Japan revealed EGCG attenuates obesity-related hepatocarcinogenesis though suppressing the IGF/IGF-1R axis, alleviating hyperinsulinemia, and reducing chronic inflammation (Shimizu et al., 2011b). This evidence concerns the gene IGF1R and obesity disorder.